According to Onconova Therapeutics's latest financial reports the company's current earnings (TTM) are -$18.95 M. In 2022 the company made an earning of -$18.97 M a decrease over its 2021 earnings that were of -$16.17 M.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | -$18.95 M | -0.08% |
2022 | -$18.97 M | 17.33% |
2021 | -$16.17 M | -35.74% |
2020 | -$25.16 M | 17.03% |
2019 | -$21.5 M | 4.67% |
2018 | -$20.54 M | -14.73% |
2017 | -$24.08 M | 22.53% |
2016 | -$19.66 M | -18.14% |
2015 | -$24.01 M | -62.36% |
2014 | -$63.78 M | 2.66% |
2013 | -$62.13 M | 107.68% |
2012 | -$29.92 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
Baxter BAX | -$47 M | 148.05% | ๐บ๐ธ USA |
Spectrum Pharmaceuticals
SPPI | -$61.89 M | 226.58% | ๐บ๐ธ USA |
CTI BioPharma
CTIC | -$69.24 M | 265.42% | ๐บ๐ธ USA |
Cleveland BioLabs
CBLI | -$2.76 M | -85.47% | ๐บ๐ธ USA |
Array Technologies ARRY | $0.21 B | -1,254.14% | ๐บ๐ธ USA |